vs

Side-by-side financial comparison of Kiniksa Pharmaceuticals International, plc (KNSA) and LATTICE SEMICONDUCTOR CORP (LSCC). Click either name above to swap in a different company.

Kiniksa Pharmaceuticals International, plc is the larger business by last-quarter revenue ($202.1M vs $145.8M, roughly 1.4× LATTICE SEMICONDUCTOR CORP). Kiniksa Pharmaceuticals International, plc runs the higher net margin — 7.0% vs -5.2%, a 12.3% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 9.3%). Kiniksa Pharmaceuticals International, plc produced more free cash flow last quarter ($53.3M vs $44.0M). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 8.4%).

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

Lattice Semiconductor Corporation is an American semiconductor company specializing in the design and manufacturing of low power field-programmable gate arrays (FPGAs). Headquartered in the Silicon Forest area of Hillsboro, Oregon, the company also has operations in San Jose, Calif., Shanghai, Manila, Penang, and Singapore. Lattice Semiconductor has more than 1000 employees and an annual revenue of more than $660 million as of 2022. The company was founded in 1983 and went public in 1989. It ...

KNSA vs LSCC — Head-to-Head

Bigger by revenue
KNSA
KNSA
1.4× larger
KNSA
$202.1M
$145.8M
LSCC
Growing faster (revenue YoY)
KNSA
KNSA
+55.7% gap
KNSA
65.0%
9.3%
LSCC
Higher net margin
KNSA
KNSA
12.3% more per $
KNSA
7.0%
-5.2%
LSCC
More free cash flow
KNSA
KNSA
$9.3M more FCF
KNSA
$53.3M
$44.0M
LSCC
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
8.4%
LSCC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KNSA
KNSA
LSCC
LSCC
Revenue
$202.1M
$145.8M
Net Profit
$14.2M
$-7.6M
Gross Margin
89.6%
68.5%
Operating Margin
9.8%
30.7%
Net Margin
7.0%
-5.2%
Revenue YoY
65.0%
9.3%
Net Profit YoY
259.8%
14.6%
EPS (diluted)
$0.18
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KNSA
KNSA
LSCC
LSCC
Q1 26
$145.8M
Q4 25
$202.1M
Q3 25
$180.9M
$133.3M
Q2 25
$156.8M
$124.0M
Q1 25
$137.8M
$120.2M
Q4 24
$122.5M
$117.4M
Q3 24
$112.2M
$127.1M
Q2 24
$108.6M
$124.1M
Net Profit
KNSA
KNSA
LSCC
LSCC
Q1 26
$-7.6M
Q4 25
$14.2M
Q3 25
$18.4M
$2.8M
Q2 25
$17.8M
$2.9M
Q1 25
$8.5M
$5.0M
Q4 24
$-8.9M
$16.5M
Q3 24
$-12.7M
$7.2M
Q2 24
$-3.9M
$22.6M
Gross Margin
KNSA
KNSA
LSCC
LSCC
Q1 26
68.5%
Q4 25
89.6%
Q3 25
88.8%
67.9%
Q2 25
88.1%
68.4%
Q1 25
87.0%
68.0%
Q4 24
85.4%
61.1%
Q3 24
82.1%
69.0%
Q2 24
88.7%
68.3%
Operating Margin
KNSA
KNSA
LSCC
LSCC
Q1 26
0.7%
Q4 25
9.8%
Q3 25
13.3%
-1.2%
Q2 25
12.9%
3.8%
Q1 25
9.6%
5.8%
Q4 24
-15.7%
-10.4%
Q3 24
-8.6%
5.9%
Q2 24
-0.1%
18.2%
Net Margin
KNSA
KNSA
LSCC
LSCC
Q1 26
-5.2%
Q4 25
7.0%
Q3 25
10.2%
2.1%
Q2 25
11.4%
2.3%
Q1 25
6.2%
4.2%
Q4 24
-7.3%
14.1%
Q3 24
-11.3%
5.7%
Q2 24
-3.6%
18.2%
EPS (diluted)
KNSA
KNSA
LSCC
LSCC
Q1 26
$-0.06
Q4 25
$0.18
Q3 25
$0.23
$0.02
Q2 25
$0.23
$0.02
Q1 25
$0.11
$0.04
Q4 24
$-0.11
$0.12
Q3 24
$-0.18
$0.05
Q2 24
$-0.06
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KNSA
KNSA
LSCC
LSCC
Cash + ST InvestmentsLiquidity on hand
$414.1M
$133.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$567.6M
$714.1M
Total Assets
$763.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KNSA
KNSA
LSCC
LSCC
Q1 26
$133.9M
Q4 25
$414.1M
Q3 25
$352.1M
$117.9M
Q2 25
$307.8M
$107.2M
Q1 25
$268.3M
$127.6M
Q4 24
$243.6M
$136.3M
Q3 24
$223.8M
$124.3M
Q2 24
$218.8M
$109.2M
Stockholders' Equity
KNSA
KNSA
LSCC
LSCC
Q1 26
$714.1M
Q4 25
$567.6M
Q3 25
$535.4M
$706.4M
Q2 25
$495.0M
$687.0M
Q1 25
$457.5M
$707.9M
Q4 24
$438.4M
$710.9M
Q3 24
$437.0M
$703.5M
Q2 24
$435.1M
$698.8M
Total Assets
KNSA
KNSA
LSCC
LSCC
Q1 26
$883.1M
Q4 25
$763.6M
Q3 25
$712.3M
$844.4M
Q2 25
$661.1M
$808.6M
Q1 25
$599.3M
$823.6M
Q4 24
$580.6M
$843.9M
Q3 24
$555.3M
$853.7M
Q2 24
$542.4M
$827.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KNSA
KNSA
LSCC
LSCC
Operating Cash FlowLast quarter
$53.9M
$57.6M
Free Cash FlowOCF − Capex
$53.3M
$44.0M
FCF MarginFCF / Revenue
26.4%
30.2%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$136.4M
$153.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KNSA
KNSA
LSCC
LSCC
Q1 26
$57.6M
Q4 25
$53.9M
Q3 25
$33.7M
$47.1M
Q2 25
$28.1M
$38.5M
Q1 25
$22.3M
$31.9M
Q4 24
$18.8M
$45.4M
Q3 24
$-2.2M
$44.0M
Q2 24
$5.2M
$21.9M
Free Cash Flow
KNSA
KNSA
LSCC
LSCC
Q1 26
$44.0M
Q4 25
$53.3M
Q3 25
$33.0M
$34.0M
Q2 25
$27.9M
$31.3M
Q1 25
$22.2M
$23.3M
Q4 24
$18.6M
$39.7M
Q3 24
$39.4M
Q2 24
$14.8M
FCF Margin
KNSA
KNSA
LSCC
LSCC
Q1 26
30.2%
Q4 25
26.4%
Q3 25
18.2%
25.5%
Q2 25
17.8%
25.2%
Q1 25
16.1%
19.4%
Q4 24
15.2%
33.8%
Q3 24
31.0%
Q2 24
11.9%
Capex Intensity
KNSA
KNSA
LSCC
LSCC
Q1 26
9.3%
Q4 25
0.3%
Q3 25
0.4%
9.8%
Q2 25
0.1%
5.8%
Q1 25
0.1%
7.2%
Q4 24
0.2%
4.9%
Q3 24
0.0%
3.7%
Q2 24
0.0%
5.8%
Cash Conversion
KNSA
KNSA
LSCC
LSCC
Q1 26
Q4 25
3.80×
Q3 25
1.83×
16.86×
Q2 25
1.58×
13.23×
Q1 25
2.61×
6.35×
Q4 24
2.75×
Q3 24
6.12×
Q2 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons